Unveiling Sex Differences in Heart Transplant Outcomes: Insights from HCM Patients Under 2018 UNOS Donor Heart Allocation Policy
Document Type
Conference Proceeding - Restricted Access
Publication Date
5-9-2025
Abstract
Hypertrophic cardiomyopathy (HCM) does not have a predilection for gender; however, underrecognition and delayed diagnosis disproportionately affects women, leading to higher incidence of advanced heart failure. End stage HCM (non-obstructive) is an increasing cause of morbidity and mortality, with HCM patients accounting for 3.5% of heart transplant (HT) recipients. Recent changes in the UNOS donor heart allocation policy acknowledged the unique pathophysiology of HCM-related advanced heart failure and led to an increase in the number of transplants. This study aims to investigate sex-based differences in HCM patients undergoing HT following the adoption of the 2018 UNOS donor heart allocation policy.
Recommended Citation
Patel N, Fermin D, Jani M, Manandhar Shrestha N, Loyaga-Rendon R. Unveiling sex differences in heart transplant outcomes: insights from HCM patients under 2018 UNOS donor heart allocation policy. Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.
Comments
2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1820